Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 4.13M | $ 2.81M | 67.93% |
3/31/2025 | $ 6.25M | $ 2.52M | 40.36% |
12/31/2024 | $ 8.61M | $ 2.94M | 34.17% |
9/30/2024 | $ 13.59M | $ 3.4M | 25.03% |
6/30/2024 | $ 15.71M | $ 3.36M | 21.37% |
3/31/2024 | $ 16.19M | $ 3.35M | 20.69% |
12/31/2023 | $ 19.38M | $ 718K | 3.7% |
9/30/2023 | $ 27.86M | $ 750K | 2.69% |
6/30/2023 | $ 33.62M | $ 803K | 2.39% |
3/31/2023 | $ 37.46M | $ 814K | 2.17% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for AIM IMMUNOTECH INC is calculated as follows: Debt [ $ 2.35M ] / Assets [ $ 64.16M ]
(=) Debt to Assets [ 3.66% ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.37K |
---|---|
min | 0% |
max | 116.6% |
average | 26.33% |
median | 21.09% |
std | 24.49% |